Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued to the public [1]. Group 1: Company Performance - Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which is a 10% year-over-year increase, but this figure fell short of the consensus estimate of $20.9 million [3]. - The company had previously released preliminary third-quarter sales figures in June, which were also lower than expectations, reporting between $19 million to $20 million against a consensus of $22.78 million [3]. - Following the release of the third-quarter earnings report, Simulations Plus stock experienced a significant decline of 25.75% on July 15, 2025 [3]. Group 2: Legal Action - Rosen Law Firm is preparing a class action lawsuit seeking recovery of investor losses for those who purchased Simulations Plus securities, with no out-of-pocket fees or costs through a contingency fee arrangement [2]. - Investors interested in joining the class action can submit their information through the Rosen Law Firm's website or contact them directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].

Core Insights - Simulations Plus, Inc. has announced the extension of two research collaborations with the FDA and NIEHS, focusing on new approach methodologies (NAMs) and computational approaches for food and chemical safety assessments [1][2][4] FDA Research Collaboration - The collaboration with the FDA's Human Foods Program will continue to utilize computational models for chemical safety assessments related to food substances [4] - The FDA has chosen to extend this collaboration to enhance AI-based safety models, supported by new federal funding aimed at modernizing food and chemical safety [5] NIEHS Research Collaboration - The partnership with NIEHS will concentrate on computational methods relevant to environmental and exposure-related chemical safety research, aligning with NIEHS's mission to investigate environmental impacts on human health [6][7] - This collaboration is part of a national initiative to modernize chemical safety assessments using AI-driven methodologies [7] Advancing NAM Research - The extensions of these collaborations indicate a sustained federal interest in computational and AI-based approaches, areas where Simulations Plus has established technical expertise over the years [8] - The company has been instrumental in developing model-informed drug development practices for 30 years, contributing to standardized methods accepted by both industry and regulators [9]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued to the public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Simulations Plus securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On July 15, 2025, an article published by Benzinga reported that Simulations Plus experienced weaker demand, leading to a decline in stock price [3]. - The company reported sales of $20.4 million for the third quarter of 2025, which was a 10% year-over-year increase but fell short of the consensus estimate of $20.9 million [3]. - Preliminary sales figures released in June indicated lower expectations, with estimates ranging from $19 million to $20 million, compared to a consensus of $22.78 million [3]. - Following the news, Simulations Plus stock fell by 25.75% on July 15, 2025 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued to the public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Simulations Plus securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On July 15, 2025, an article published by Benzinga indicated that Simulations Plus experienced weaker demand, leading to a decline in stock price [3]. - The company reported sales of $20.4 million for the third quarter of 2025, which was a 10% year-over-year increase but fell short of the consensus estimate of $20.9 million [3]. - Preliminary sales figures released in June indicated lower expectations, with estimates ranging from $19 million to $20 million, compared to a consensus of $22.78 million [3]. - Following the news, Simulations Plus stock fell by 25.75% on July 15, 2025 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Company Performance - Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which is a 10% year-over-year increase but fell short of the consensus estimate of $20.9 million [3]. - The company had previously released preliminary third-quarter sales figures in June, which were already lower than expectations at $19 million to $20 million, compared to a consensus of $22.78 million [3]. - Following the earnings report, Simulations Plus stock experienced a significant decline of 25.75% on July 15, 2025 [3]. Group 2: Legal Action - Investors who purchased Simulations Plus securities may be entitled to compensation through a class action lawsuit being prepared by Rosen Law Firm, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4].

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Simulations Plus securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket fees or costs [2]. - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On July 15, 2025, Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which was a 10% year-over-year increase but fell short of the consensus estimate of $20.9 million [3]. - The company had previously released preliminary sales figures in June that were lower than expectations, with estimates ranging from $19 million to $20 million compared to a consensus of $22.78 million [3]. - Following the earnings report, Simulations Plus stock experienced a significant decline of 25.75% on July 15, 2025 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Company Performance - Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which is a 10% year-over-year increase but fell short of the consensus estimate of $20.9 million [3]. - The company had previously released preliminary third-quarter sales figures in June, which were already lower than expectations at $19 million to $20 million, compared to a consensus of $22.78 million [3]. - Following the earnings report, Simulations Plus stock experienced a significant decline of 25.75% on July 15, 2025 [3]. Group 2: Legal Action - Investors who purchased Simulations Plus securities may be entitled to compensation through a class action lawsuit being prepared by Rosen Law Firm, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly for more information [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4].

Group 1 - The biopharma industry is undergoing significant transformation, driven by the adoption of AI, cloud-native scientific computation, a shift away from animal testing, and increased reliance on model-informed drug development [3] - Simulations Plus is positioning itself to meet the industry's inflection point by enhancing its technology, services, and operating model, thereby strengthening its leadership and building an integrated ecosystem for future innovation [3] Group 2 - The agenda for the Investor Day includes an overview of the company's vision, mission, and values, highlights of company growth, major business components, industry environment, challenges and opportunities in drug development, software product strategy, fiscal year '26 roadmap, and a Q&A session [2] - The company is approaching its 30th anniversary, reflecting on its history of growth and the evolution of its business [2]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued to the public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Simulations Plus securities may be entitled to compensation through a class action without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Simulations Plus [2]. Group 2: Company Performance and Market Reaction - Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which is a 10% year-over-year increase but below the consensus estimate of $20.9 million [3]. - The company had previously released preliminary sales figures of $19 million to $20 million, which were also lower than the consensus estimate of $22.78 million [3]. - Following the earnings report and the negative outlook, Simulations Plus' stock fell by 25.75% on July 15, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and success in this area [4].